Verinata Health has introduced a non-invasive prenatal test to detect autosomal and fetal sex chromosome aneuploidies for high-risk pregnancies.
The expanded indication of verifi prenatal blood test detects Turner syndrome (Monosomy X), Triple X (XXX), Klinefelter syndrome (XXY) and Jacob’s syndrome (XYY), in addition to Down syndrome (trisomy 21 or T21), Edwards syndrome (trisomy 18 or T18) and Patau syndrome (trisomy 13 or T13).
The test, which analyzes genetic material, also has the ability to stratify the risk of X-linked disorders such as hemophilia, Duchenne muscular dystrophy or cases of ambiguous genitalia such as congenital adrenal hyperplasia.
KS&A executive director Jim Moore said X or Y chromosome variations are found in one in 500 babies born in the US.
"Early identification and subsequent intervention could end the ‘diagnostic odyssey’ and lifetime of struggle that so many face as a result of never being diagnosed," Moore added.
"KS&A stands ready to serve this community through educational resources and support."
KS&A is an organization dedicated to helping people with one or more extra X or Y chromosomes lead fuller, more productive lives.